Eli Lilly, venture fund and Andreessen Horowitz

Waves of hype have been unleashed on the public since ChatGPT’s unveiling in 2022. And investors have no intention of slowing ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.